ArticleOncotarget2017

HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Teresa L Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.